The Incidence and Impact of Permanent Right Ventricular Infarction on Left Ventricular Infarct Size in Patients With Inferior ST-Segment Elevation Myocardial Infarction.


Journal

The American journal of cardiology
ISSN: 1879-1913
Titre abrégé: Am J Cardiol
Pays: United States
ID NLM: 0207277

Informations de publication

Date de publication:
01 01 2023
Historique:
received: 17 07 2022
revised: 02 10 2022
accepted: 13 10 2022
pubmed: 8 11 2022
medline: 7 12 2022
entrez: 7 11 2022
Statut: ppublish

Résumé

Mounting evidence shows that right ventricle (RV) function carries independent prognostic influence in various disease states. This study aimed to investigate the incidence and impact of permanent RV infarction in patients with inferior ST-segment elevation myocardial infarction (STEMI) and culprit lesion in the right coronary artery (RCA). In this substudy of the DANAMI-3 (DANish Study of Optimal Acute Treatment of Patients with ST-segment Elevation Myocardial Infarction) trial, cardiac magnetic resonance was performed in 291 patients at day 1 and follow-up 3 months after primary percutaneous coronary intervention of 674 patients with STEMI with the culprit lesion in the RCA. Final infarct was assessed using late gadolinium enhancement on cardiac magnetic resonance at 3 months. Patients with permanent RV infarction (20%) had lower ventricular function at follow-up; RV ejection fraction (EF) 47% ±6 versus 50% ± 5 (p <0.005) and left ventricular (LV) EF 56% ± 8 versus 60% ± 9 (p <0.006). Furthermore, patients with permanent RV infarction had a higher incidence of microvascular obstruction 39 (67%) versus 81 (39%) (p <0.001), larger final LV infarct size 16% ±8 versus 10% ± 8 (p <0.001) and larger LV area at risk 33% ± 10 versus 29% ± 9 (p <0.001). Permanent RV infarction was an independent predictor of final LV infarct size (p <0.001) but was not associated with LVEF (β = -0.0; p = 0.13) in multivariable analyses. In conclusion, permanent RV infarction was seen in 20% of patients with inferior STEMI and culprit lesion in RCA and independently predicted final LV infarct size. However, permanent RV infarction did not predict overall LV function. LGE was used to detect infarct location and quantify infarct size.

Identifiants

pubmed: 36343445
pii: S0002-9149(22)01115-8
doi: 10.1016/j.amjcard.2022.10.022
pii:
doi:

Substances chimiques

Gadolinium AU0V1LM3JT
Contrast Media 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

43-49

Informations de copyright

Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.

Auteurs

Anne-Sophie Juul (AS)

Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Denmark; Faculty of Health Science, University of Copenhagen. Electronic address: annesophie.juul@gmail.com.

Kasper Kyhl (K)

Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Denmark.

Kathrine Ekström (K)

Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Denmark.

Jasmine Melissa Madsen (JM)

Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Denmark.

Muhammad Sabbah (M)

Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Denmark.

Kiril Aleksov Ahtarovski (KA)

Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Denmark.

Lars Nepper-Christensen (L)

Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Denmark.

Niels Vejlstrup (N)

Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Denmark.

Dan Høfsten (D)

Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Denmark.

Henning Kelbaek (H)

Department of Cardiology, Zealand University Hospital, Roskilde, Denmark.

Lars Køber (L)

Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Denmark.

Jacob Lønborg (J)

Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Denmark.

Thomas Engstrøm (T)

Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH